New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
Facing Lung Cancer Together
November was National Lung Cancer Awareness Month, and Fox Chase Cancer Center started off the month with Together Facing Lung Cancer, an event that united lung cancer survivors, caregivers, and health care professionals for an evening of education, discuss...
Read More
Facing Lung Cancer Together
Exciting News in the Fight Against Lung Cancer
A news story in USA Today’s January 13, 2015 edition reported that a new cancer drug, Opdivo, is working so successfully that maker Bristol-Myers Squibb announced this week that it is ending a trial in lung cancer two years ahead of schedule. “We partici...
Read More
Exciting News in the Fight Against Lung Cancer
Fox Chase Clinical Trial Patient is Invited to Eagles Home Game
Over the last three years, the Chris Draft Family Foundation has been leading a national campaign to change the face of lung cancer. Chris Draft, a former NFL linebacker, has devoted much of his time the past three years to raising awareness about lung c...
Read More
Fox Chase Clinical Trial Patient is Invited to Eagles Home Game
Join former NFL player, Chris Draft, at Together Facing Lung Cancer
It’s quite uncommon to find a former NFL linebacker visiting a National Cancer Institute (NCI) designated comprehensive cancer center, much less one who visited all 41 NCI centers last year. But when you meet Chris Draft, the reason becomes clear. His...
Read More
Join former NFL player, Chris Draft, at Together Facing Lung Cancer
Lung-Sparing Treatment Options for Malignant Pleural Mesothelioma
Malignant pleural mesothelioma is a thoracic disease process that affects those with prior inhalational exposure to asbestos. It originates in the pleural space and progresses by local extension to involve the ipsilateral lung and adjacent structures....
Read More
Lung-Sparing Treatment Options for Malignant Pleural Mesothelioma
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this